Literature DB >> 18480076

New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'.

Bas A Schoonderwoerd1, Marcelle D Smit, Lucas Pen, Isabelle C Van Gelder.   

Abstract

Atrial fibrillation (AF) is a prevalent arrhythmia in patients with cardiovascular disease. The classical risk factors for developing AF include hypertension, valvular disease, (ischaemic) cardiomyopathy, diabetes mellitus, and thyroid disease. In some patients with AF, no underlying (cardiovascular) pathology is present and the aetiology remains unknown. This condition is known as lone AF. However, in recent years, other factors playing a role in the genesis of AF have gained attention, including obesity, sleep apnoea, alcohol abuse and other intoxications, excessive sports practice, latent hypertension, genetic factors, and inflammation. In this review, we address these 'new risk factors' (i.e. as opposed to the classical risk factors) and the mechanisms by which they lead to AF.

Entities:  

Mesh:

Year:  2008        PMID: 18480076     DOI: 10.1093/europace/eun124

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  46 in total

1.  Alcohol consumption and risk of stroke in women.

Authors:  Monik Jimenez; Stephanie E Chiuve; Robert J Glynn; Meir J Stampfer; Carlos A Camargo; Walter C Willett; Joann E Manson; Kathryn M Rexrode
Journal:  Stroke       Date:  2012-03-08       Impact factor: 7.914

Review 2.  Computational approaches to structural and functional analysis of plastocyanin and other blue copper proteins.

Authors:  F De Rienzo; R R Gabdoulline; R C Wade; M Sola; M C Menziani
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

3.  The relation between different dimensions of alcohol consumption and burden of disease: an overview.

Authors:  Jürgen Rehm; Dolly Baliunas; Guilherme L G Borges; Kathryn Graham; Hyacinth Irving; Tara Kehoe; Charles D Parry; Jayadeep Patra; Svetlana Popova; Vladimir Poznyak; Michael Roerecke; Robin Room; Andriy V Samokhvalov; Benjamin Taylor
Journal:  Addiction       Date:  2010-03-15       Impact factor: 6.526

4.  AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-12-09

5.  Are glucocorticoids a treatment or a risk factor?

Authors:  Michiel Rienstra; Isabelle C Van Gelder
Journal:  Nat Rev Cardiol       Date:  2010-03       Impact factor: 32.419

6.  Acute sleep deprivation in healthy adults is associated with a reduction in left atrial early diastolic strain rate.

Authors:  Göksel Açar; Mustafa Akçakoyun; Ibrahim Sari; Mustafa Bulut; Elnur Alizade; Birol Özkan; Mehmet Vefik Yazicioğlu; Gökhan Alici; Anil Avci; Ramazan Kargin; Ali Metin Esen
Journal:  Sleep Breath       Date:  2012-11-16       Impact factor: 2.816

7.  Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study.

Authors:  Hemal Bhatt; Christopher M Gamboa; Monika M Safford; Elsayad Z Soliman; Stephen P Glasser
Journal:  J Am Soc Hypertens       Date:  2016-05-30

8.  A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study.

Authors:  Matthew Knuiman; Tom Briffa; Mark Divitini; Derek Chew; John Eikelboom; Brendan McQuillan; Joseph Hung
Journal:  Eur J Epidemiol       Date:  2014-01-04       Impact factor: 8.082

9.  Usefulness of pharmacologic conversion of atrial fibrillation during dofetilide loading without the need for electrical cardioversion to predict durable response to therapy.

Authors:  Rohit Malhotra; Kenneth C Bilchick; John P DiMarco
Journal:  Am J Cardiol       Date:  2013-11-09       Impact factor: 2.778

10.  Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity.

Authors:  J Gustav Smith; Pyotr G Platonov; Bo Hedblad; Gunnar Engström; Olle Melander
Journal:  Eur J Epidemiol       Date:  2010-02       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.